• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Fluorouracil Injection 50mg/mL, (500 mg/10mL Single Dose Vial)

Audience: Oncologists, pharmacists, and other healthcare professionals

[Posted 09/27/2005] American Pharmaceutical Partners, Inc. and FDA notified healthcare professionals about a nationwide recall of Fluorouracil Injection 50 mg/mL (500 mg/10ml Single Dose Vial) because of the potential for invisible glass particles containing silica and aluminum in vials of the product. The company states that only Product code 101710 is susceptible to this type of glass breakdown.

[September 2005 - Product Recall - American Pharmaceutical Partners, Inc.]
[September 2005 - Dear Healthcare Professional Letter - American Pharmaceutical Partners, Inc.]